about
The incidence of adverse events and risk factors for upper gastrointestinal disorders associated with meloxicam use amongst 19,087 patients in general practice in England: cohort studyRecord linkage for drug monitoringDesign issues for drug epidemiology.Pharmacovigilance: a science or fielding emergencies?Detection of drug-induced diseaseA comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions.Identification of adverse reactions to new drugs. II--How were 18 important adverse reactions discovered and with what delays?Identification of adverse reactions to new drugs. II (continued): How were 18 important adverse reactions discovered and with what delays?Adverse drug reactions during hospitalization.PharmacovigilanceComputers in medicine: past, present, and potential.Prospective observational study of adverse drug reactions to diclofenac in childrenSumatriptan therapy for headache and acute myocardial infarction.Prospective cohort study of adverse events monitored by hospital pharmacists. Hospital Adverse Event Monitoring Study (HAEMS) Group.What constitutes good prescribing?Different risks for NSAID-induced anaphylaxis.The hope, hype and reality of Big Data for pharmacovigilance.Evaluating the safety of medicines, with particular reference to contraception.The case for recording events in clinical trials.
P2860
Q33333061-40963EB2-609A-479C-8D98-C9E26D36645CQ33684132-0DB15C68-BA8F-4D77-A4FB-B16904FEA7FAQ34078588-E3846EA9-F481-4180-8644-E6AEA34AEDBCQ34103107-E7441B7E-696E-4C38-95CF-EE64D40729E5Q34517425-8FC9341E-5D2E-4F4B-AF34-8772544C5176Q34629802-60DFAA02-83FF-4A96-B4AF-CCC2D4514E2AQ34990185-F06F40E7-2C26-428D-A837-B606E9778891Q34990937-7A07B91F-7E5F-4A2C-AA11-67665B6379CBQ35899408-DE2A8B06-2CEA-4AF2-ABD9-503F49A4DE94Q36081511-8A4513F3-477E-4B62-8556-8771D6F667C2Q36583682-90169783-C2A1-4C65-AF45-5A58F8CBBD11Q37399454-A6083CF2-445F-4675-AF07-72C92E2F9ACAQ37803238-22192DB0-017A-426A-9A71-D71995DA177EQ40692156-3C48CE5F-59A1-4DF0-A9FC-206A0ED18D60Q41772391-B8E996C8-0BC9-434D-9D37-DCBBAEFCEECEQ43869915-C800EA08-DDF6-45FE-BB9A-D7A88B0AA568Q47561263-B055BE31-789B-40DA-BBF4-3205E7C0D1DDQ52936191-CF0A237B-A25A-40DE-85CC-4FEF91DDA75DQ55519604-3992A440-F097-46B1-8357-232E837BF85D
P2860
description
1965 nî lūn-bûn
@nan
1965年の論文
@ja
1965年学术文章
@wuu
1965年学术文章
@zh
1965年学术文章
@zh-cn
1965年学术文章
@zh-hans
1965年学术文章
@zh-my
1965年学术文章
@zh-sg
1965年學術文章
@yue
1965年學術文章
@zh-hant
name
THE DESIGN AND LOGIC OF A MONITOR OF DRUG USE.
@en
THE DESIGN AND LOGIC OF A MONITOR OF DRUG USE.
@nl
type
label
THE DESIGN AND LOGIC OF A MONITOR OF DRUG USE.
@en
THE DESIGN AND LOGIC OF A MONITOR OF DRUG USE.
@nl
prefLabel
THE DESIGN AND LOGIC OF A MONITOR OF DRUG USE.
@en
THE DESIGN AND LOGIC OF A MONITOR OF DRUG USE.
@nl
P1476
THE DESIGN AND LOGIC OF A MONITOR OF DRUG USE.
@en
P2093
P356
10.1016/0021-9681(65)90054-8
P577
1965-01-01T00:00:00Z